Citation Impact
Citing Papers
Immunotherapy of cancer in 2012
2012
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats
2012
Mechanisms of hepatic stellate cell activation
2017 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Hepatocellular carcinoma
2021 Standout
High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutations
2004
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
2012
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Hepatocellular carcinoma
2022 Standout
Prostate Cancer
2019
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Works of Mengsen Li being referenced
Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes
2009
α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand
2007
The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line
2002
High C-X-C motif chemokine�5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways
2018
Structural basis for alpha fetoprotein‐mediated inhibition of caspase‐3 activity in hepatocellular carcinoma cells
2017